Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...

While OTC products have lower margins ... The announcement sparked speculation that a number of health companies would be interested in buying the Pfizer business. These include GlaxoSmithKline ...

Reviewed by David Kindness Pfizer Inc. (PFE) is a global biopharmaceutical company based in New York. The company makes money ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

Valued at a market cap of $152.2 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company dedicated to advancing ...

Pfizer’s latest-generation pneumococcal conjugate vaccine is in line to reach more people in Latin America and the Caribbean ...

Pfizer shares have lost more than half their value since peaking in late 2021, when sales of pandemic products were still strong. Meanwhile, Bourla has done a series of deals worth $70 billion ...

Pfizer’s chief scientific officer, in an interview. Study participants were unvaccinated, with mild-to-moderate COVID-19, and were considered high risk for hospitalization due to health problems ...

Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily ... by the Medicines and Healthcare products Regulatory Agency (MHRA) as ...

The latest disposal reduced Pfizer's interest in Haleon to 7.3% from 15%. JPMorgan and Morgan Stanley acted as joint global coordinators and joint bookrunners for the sale. GSK sold its remaining 4.2% ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.